US FDA Changing View Of Citizen Petition Response Time, Could Eliminate Serial Refiling
Executive Summary
By aligning petition filing deadlines with user fee goals, agency could discourage petitions that need response within 150 days, potentially ending non-substantive response practice.
You may also be interested in...
Former Official Petitions US FDA To Stop Reviewing Russian Firms' Applications Amid Ukraine Invasion
Request from Tim Coté, former Office of Orphan Products Development director, could drag agency back into a political arena it's been trying to avoid. Coté, now consulting through Only Orphans Coté, filed a citizen petition asking agency to “completely freeze all administrative actions on any regulatory requests,” from drug and device companies headquartered in Russia or with majority Russian ownership.
Ex-US FDA Official Petitions Agency To Stop Reviewing Applications From Russian Companies Amid War In Ukraine
The request could drag the agency back into a political arena it has been trying to avoid.
International Pricing Index Could Suffer From Industry Gaming
Former US FDA commissioner Scott Gottlieb doesn't "want to give too much away," but expresses skepticism about Trump administration's ability to implement its international price index proposal, noting there are ways for brand companies to game the system.